VeriMomcannabis sativa flower extract hamilelikte güvenli mi?
No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
Pregnancy-safe products containing cannabis sativa flower extract
Related ingredients
Frequently asked questions
- cannabis sativa flower extract hamilelikte güvenli mi?
- No harmonised CLP reproductive classification for 'cannabis sativa flower extract' and no CIR or SCCS safety assessment identifying reproductive hazard for the botanical extract in cosmetic topical use. While systemic cannabinoids (e.g., Δ9‑THC) have reported reproductive effects in some studies, those refer to systemic exposure; topical cosmetic use of a botanical extract is expected to give negligible systemic exposure. Sources: ECHA Annex VI (no harmonised classification for this extract), CIR (no cosmetic safety assessment flag), PubMed (studies on systemic cannabinoid reproductive effects).
- cannabis sativa flower extract emzirirken güvenli mi?
- No authoritative classification or safety assessment (CIR/SCCS/ECHA harmonised) identifying breastfeeding-specific hazard for topical 'cannabis sativa flower extract'. Transfer to breast milk would require systemic absorption of cannabinoids; topical cosmetic use is expected to produce negligible maternal systemic levels. Sources: ECHA Annex VI (no harmonised classification), CosIng (ingredient listing), PubMed (systemic cannabinoid transfer studies noted but not applicable to low topical exposures).
- cannabis sativa flower extract bebek cildi için güvenli mi?
- No evidence of intrinsic reproductive or developmental hazard of the botanical extract for infant topical use in authoritative sources. However, infant skin has higher per‑kg absorption and an immature barrier; if the extract contains measurable cannabinoids or other small lipophilic constituents there is potential for greater dermal uptake in 0–3 yr olds than adults. Therefore exposure score is increased by +1 (from adult negligible to low but measurable). Sources: CosIng (ingredient present in cosmetic inventories), general dermal absorption principles and PubMed literature on cannabinoid absorption (systemic effects relate to systemic exposure, not topical cosmetic use).
- VeriMom cannabis sativa flower extract nasıl puanlıyor?
- VeriMom cannabis sativa flower extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte cannabis sativa flower extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.